Natural history of pituitary incidentalomas in pediatric patients: a single-center, retrospective analysis

Alexander C Waselewski1, Lisa M Walsh2, Katherine G Holste3

  • 1Department of Pediatric Endocrinology, University of Michigan, Ann Arbor, MI 48109, USA.

Insights

Pediatric pituitary incidentalomas are typically benign, with no patients developing new symptoms. Clinical monitoring may be sufficient for these incidental findings in children.

Area of Science:

  • Pediatric Endocrinology
  • Pediatric Neurosurgery
  • Neuroradiology

Background:

  • Advanced imaging increasingly identifies pediatric pituitary incidentalomas.
  • Limited data exists on the prognosis and management of these nonfunctioning pituitary abnormalities in children.

Purpose of the Study:

  • To describe clinical features and course of pediatric patients with incidental pituitary lesions.
  • To identify predictors of endocrinopathy or neurological symptoms in pediatric pituitary incidentalomas.

Main Methods:

  • Retrospective observational study over 24 years at a single tertiary care children's hospital.
  • Reviewed electronic health records of pediatric patients with pituitary incidentalomas identified on MRI.
  • Analyzed patient characteristics, clinical course, and serial imaging.

Main Results:

  • Thirty-five pediatric pituitary incidentalomas were identified; most were microincidentalomas and cystic.
  • Headache was the most common reason for initial MRI.
  • No patient developed endocrinopathy or new neurological symptoms during a median 23-month follow-up.

Conclusions:

  • Pediatric pituitary incidentalomas appear to be benign with a favorable prognosis.
  • Clinical monitoring without routine imaging or lab tests may be appropriate for asymptomatic pediatric patients.
  • Further research is needed to establish definitive guidelines for managing pediatric pituitary incidentalomas.
Abstract

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
What is Evolutionary History?02:35

What is Evolutionary History?

Scientists record evolutionary history by analyzing fossil, morphological, and genetic data. The fossil record documents the history of life on Earth and provides evidence for evolution. However, both fossil and living organisms offer evidence that outlines Earth’s evolutionary history.
43.6K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
66.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236